Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Alberini

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2023
Diagnostic effectiveness of [<sup>18</sup>F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective studyGianluca Bottoni, Francesco Fiz, Matteo Puntoni, et al.
Rheumatology (Oxford, England)|July 22, 2022
PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritisThomas Thibault, Bastien Durand-Bailloud, Agnès Soudry-Faure, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patientsLionel Groussin, Gérald Bonardel, Stéphane Silvéra, et al.
EJNMMI Research|December 14, 2019
Dual time point [<sup>18</sup>F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissuesPierre Lovinfosse, Caroline Rousseau, Jean-Yves Pierga, et al.
European Journal of Radiology|June 17, 2021
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CTGianluca Bottoni, Arnoldo Piccardo, Francesco Fiz, et al.
Frontiers in Medicine|January 31, 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES StudyManuela Monti, Tom Degenhardt, Etienne Brain, et al.
European Journal of Internal Medicine|April 16, 2024
Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective studyAnne-Claire Billet, Thomas Thibault, Éric Liozon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2019
Good clinical practice recommendations for the use of PET/CT in oncologyPierre-Yves Salaün, Ronan Abgral, Olivier Malard, et al.
Bulletin Du Cancer|January 27, 2019
[Update of the recommendations of good clinical practice for the use of PET in oncology]Pierre-Yves Salaün, Ronan Abgral, Olivier Malard, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2023
Diagnostic effectiveness of [<sup>18</sup>F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective studyGianluca Bottoni, Francesco Fiz, Matteo Puntoni, et al.
Rheumatology (Oxford, England)|July 22, 2022
PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritisThomas Thibault, Bastien Durand-Bailloud, Agnès Soudry-Faure, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patientsLionel Groussin, Gérald Bonardel, Stéphane Silvéra, et al.
EJNMMI Research|December 14, 2019
Dual time point [<sup>18</sup>F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissuesPierre Lovinfosse, Caroline Rousseau, Jean-Yves Pierga, et al.
European Journal of Radiology|June 17, 2021
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CTGianluca Bottoni, Arnoldo Piccardo, Francesco Fiz, et al.
Frontiers in Medicine|January 31, 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES StudyManuela Monti, Tom Degenhardt, Etienne Brain, et al.
European Journal of Internal Medicine|April 16, 2024
Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective studyAnne-Claire Billet, Thomas Thibault, Éric Liozon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2019
Good clinical practice recommendations for the use of PET/CT in oncologyPierre-Yves Salaün, Ronan Abgral, Olivier Malard, et al.
Bulletin Du Cancer|January 27, 2019
[Update of the recommendations of good clinical practice for the use of PET in oncology]Pierre-Yves Salaün, Ronan Abgral, Olivier Malard, et al.
Pageof 5